English   español  

Browsing by Author Mateos, Maria Victoria

Showing results 1 to 20 of 49  next >
RightsPreviewIssue DateTitleAuthor(s)Type
closedAccessaccesoRestringido.pdf.jpg2013A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease controlPaiva, Bruno; Vidriales, Belén; Martínez-López, Joaquín; Mateos, Maria Victoria; Ocio, Enrique M.; Gutiérrez, Norma Carmen; Díaz-Mediavilla, J.; Orfao, Alberto; Lahuerta, Juan José; Bladé, Joan; San Miguel, Jesús F.Artículo
openAccess4 randomized trials.pdf.jpg2013Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trialsBringhen, Sara; Mateos, Maria Victoria; Lahuerta, Juan José; San Miguel, Jesús F.; Palumbo, AntonioArtículo
openAccessflowcytometry.pdf.jpg2013Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometryPessoa de Magalhães, Roberto J.; Vidriales, Belén; Paiva, Bruno; Fernández, Carlos; García-Sanz, Ramón; Mateos, Maria Victoria; Gutiérrez, Norma Carmen; Lecrevisse, Q.; Blanco, Juan F.; Martínez-López, Joaquín; Sobral da Costa, E.; Ocio, Enrique M.; Pérez-Andrés, Martin; Lahuerta, Juan José; San Miguel, Jesús F.; Orfao, AlbertoArtículo
closedAccessaccesoRestringido.pdf.jpg2010BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)Santamaría, Carlos; Chillón, Maria del Carmen; García-Sanz, Ramón; Caballero, Dolores; Mateos, Maria Victoria; Sarasquete, María Eugenia; Díaz-Mediavilla, J.; San Miguel, Jesús F.; González, MarcosArtículo
closedAccessaccesoRestringido.pdf.jpg2014Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapyMateos, Maria Victoria; Bringhen, Sara; Richardson, Paul G.; Lahuerta, Juan José; García-Sanz, Ramón; San Miguel, Jesús F.; Palumbo, AntonioArtículo
closedAccessaccesoRestringido.pdf.jpg2007Bortezomib in multiple myelomaMateos, Maria Victoria; San Miguel, Jesús F.Artículo
closedAccessaccesoRestringido.pdf.jpg2011Bortezomib in the upfront treatment of multiple MyelomaSan Miguel, Jesús F.; Mateos, Maria VictoriaCapítulo de libro
openAccessBortezomib Plus Melphalan.pdf.jpg2010Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA TrialMateos, Maria Victoria; San Miguel, Jesús F.Artículo
openAccessBortezomib plus.pdf.jpg2008Bortezomib plus melphalan and prednisone for initial treatment of multiple myelomaSan Miguel, Jesús F.; Mateos, Maria VictoriaArtículo
closedAccessaccesoRestringido.pdf.jpg2014Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched studyMorabito, Fortunato; Bringhen, Sara; Mateos, Maria Victoria; Lahuerta, Juan José; San Miguel, Jesús F.; Palumbo, AntonioArtículo
openAccess10.3324-haematol.2010.028027.pdf.jpg1-Nov-2010Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 studyLahuerta, Juan José; Mateos, Maria Victoria; San Miguel, Jesús F.Artículo
openAccessCan multiple myeloma.pdf.jpg2011Can multiple myeloma become a curable disease?San Miguel, Jesús F.; Mateos, Maria VictoriaArtículo
closedAccessaccesoRestringido.pdf.jpg2011Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating agents: Analysis of the VISTA trialRichardson, Paul G.; Mateos, Maria Victoria; San Miguel, Jesús F.Artículo
closedAccessaccesoRestringido.pdf.jpg2013Clinical applicability and prognostic significance of molecular response assessed by fluorescent-PCR of immunoglobulin genes in multiple myeloma. Results from a GEM/PETHEMA studyMartínez-López, Joaquín; García-Sanz, Ramón; Paiva, Bruno; Mateos, Maria Victoria; Sarasquete, María Eugenia; Bladé, Joan; San Miguel, Jesús F.; Lahuerta, Juan JoséArtículo
closedAccessaccesoRestringido.pdf.jpg2012Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patientsPaiva, Bruno; Gutiérrez, Norma Carmen; Chen, Xi; Vidriales, Belén; Martínez-López, Joaquín; Mateos, Maria Victoria; López-Corral, L.; Díaz-Rodríguez, Elena; Orfao, Alberto; Lahuerta, Juan José; Bladé, Joan; Pandiella, Atanasio; San Miguel, Jesús F.Artículo
closedAccessaccesoRestringido.pdf.jpg2011Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myelomaPaiva, Bruno; Pérez-Andrés, Martin; Almeida, Julia; Mateos, Maria Victoria; López-Corral, L.; Gutiérrez, Norma Carmen; Schmidt-Hieber, M.; Lahuerta, Juan José; San Miguel, Jesús F.; Orfao, AlbertoArtículo
openAccessrefractorymultiplemyeloma.pdf.jpg2014Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myelomaDimopoulos, Meletios A.; Palumbo, Antonio; Moreau, Philippe; Delforge, Michel; Cavo, Michele; Ludwig, Heinz; Mateos, Maria Victoria; San Miguel, Jesús F.Artículo
closedAccessaccesoRestringido.pdf.jpg2011Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. Melphalan-prednisone in the phase III VISTA trial in multiple myelomaDelforge, Michel; Mateos, Maria Victoria; San Miguel, Jesús F.Artículo
closedAccessaccesoRestringido.pdf.jpg2005Genetic abnormalities and patterns of antigenic expression in multiple myelomaMateo, Gema; Castellanos, Mariana V.; Rasillo, Ana; Gutiérrez, Norma Carmen; Hernández, Jesús M.; López-Borges, Susana; Bladé, Joan; Mateos, Maria Victoria; Díaz-Mediavilla, J.; Pandiella, Atanasio; Lahuerta, Juan José; Orfao, Alberto; San Miguel, Jesús F.Artículo
closedAccessaccesoRestringido.pdf.jpg2012High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myelomaPaiva, Bruno; Gutiérrez, Norma Carmen; Vidriales, Belén; Martínez-López, Joaquín; Mateos, Maria Victoria; Díaz-Mediavilla, J.; Lahuerta, Juan José; Bladé, Joan; San Miguel, Jesús F.Artículo